Cargando…
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding Study
Although cardiovascular mortality in Japan is lower than in other industrialized countries, clinical outcomes in coronary artery disease (CAD) patients with type 2 diabetes mellitus (T2DM) remain poor despite multiple evidence-based drug therapies and interventions. We assumed that part of residual...
Autores principales: | Miwa, Yoshikazu, Mutoh, Akiko, Morimoto, Takeshi, Ikehara, Yumi, Yasu, Takanori, Koba, Shinji, Ako, Junya, Higashi, Yukihito, Kajikawa, Masato, Uehara, Hiroki, Ishikawa, Kazuo, Sakuma, Ichiro, Tomiyama, Hirofumi, Node, Koichi, Kumagai, Yuji, Ueda, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834642/ https://www.ncbi.nlm.nih.gov/pubmed/36643381 http://dx.doi.org/10.1159/000527411 |
Ejemplares similares
-
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
por: Tanaka, Atsushi, et al.
Publicado: (2021) -
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2021) -
The clinical value of hepatojugular reflux on congestive heart failure: A meta‐analysis
por: Iwata, Hiroyoshi, et al.
Publicado: (2022) -
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
por: Kishimoto, Shinji, et al.
Publicado: (2023) -
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study
por: Oyama, Jun-ichi, et al.
Publicado: (2016)